Atezolizumab,Enzalutamide
roche,astellas,pfizer
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
using samples from phase iii imbassador250 trial, #newresearch presented at asco #gu23 confirmed strong association between a baseline ctdna tumor fraction greater than 2% at the time of switching 2nd generation hormonal therapy treatments and os in mcrpc: 
Changing the course of cancer with molecular information. #WeAreFMI

Community Guidelines: https://t.co/XTZqTXqScf